BeiGene Ltd ADR buy Guggenheim
Start price
27.02.24
/
50%
€166.00
Target price
27.02.25
€317.85
Performance (%)
60.24%
End price
28.02.25
€266.00
Summary
This prediction ended on 28.02.25 with a price of €266.00. With a performance of 60.24% the BUY prediction by Guggenheim was a big success. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BeiGene Ltd ADR | 2.083% | 2.083% | 38.679% |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% |
Comments by Guggenheim for this prediction
In the thread BeiGene Ltd ADR diskutieren
BeiGene, Ltd. (NASDAQ: BGNE) had its price target lowered by analysts at Guggenheim from $350.00 to $345.00. They now have a "buy" rating on the stock.
Ratings data for BGNE provided by MarketBeat
In the thread Trading BeiGene Ltd ADR
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Guggenheim for BeiGene Ltd ADR
BeiGene Ltd ADR
Start price
Target price
Perf. (%)
€214.00
28.02.23
28.02.23
€329.84
28.02.24
28.02.24
-26.17%
29.02.24
29.02.24
